Zepbound (Tirzepatide): A once-weekly dual agonist (GLP-1/GIP receptor agonist) injection FDA-approved for the treatment of obesity and obstructive Sleep Apnea
Lifestyle Support Encourages the adoption of balanced nutrition and physical activity routines
Speeds Up Recovery : Reduces inflammation and soreness post-workout
A 10mg vial at a maintenance dose of 8mg weekly lasts roughly 1.25 weeks, so you would need approximately 4 vials per month at full dosing
CrossRef Glucagon-Like Peptide-1 Receptor Agonists Combined With Personalized Digital Health Care for the Treatment of Metabolic Syndrome in Adults With Obesity: Retrospective Observational Study Hala Zakaria, Hadoun Jabri, Sheikha Alshehhi, Milena Caccelli, Joelle Debs, Yousef Said, Joudy Kattan, Noah Almarzooqi, Ali Hashemi, Ihsan Almarzooqi Interactive Journal of Medical Research.2025